Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study
- PMID: 35301013
- DOI: 10.1016/j.jinf.2022.03.010
Risk factors for infection and mortality caused by carbapenem-resistant Klebsiella pneumoniae: A large multicentre case-control and cohort study
Abstract
Objectives: To elucidate the predictors of carbapenem-resistant Klebsiella pneumoniae (CRKP) infection and help clinicians better identify CRKP infection at an early stage.
Methods: We conducted a multicentre case-control study of 422 patients with CRKP infection and 948 with carbapenem-susceptible K. pneumoniae (CSKP) infection from March to July 2017. Binary logistic regression was used to identify risk factors for CRKP infection. The subgroups of CRKP respiratory infection, intra-abdominal infection, and bloodstream infection were also evaluated. Patients were followed up for 28 days. Independent risk factors for 28-day crude mortality of CRKP infection were analysed using Cox proportional hazards regression models.
Results: Longer stay of hospitalization, stay in the intensive care unit (ICU), previous exposure to antibacterial agents (especially carbapenems, quinolones, aminoglycosides, and tigecycline), invasive procedures, intravascular catheter use, tracheotomy, and admission to ICU in the preceding 90 days were risk factors for CRKP infection. Carbapenem exposure was the only common predictor of different types of CRKP infection. The 28-day crude mortality of CRKP infection was 24.2% and was independently associated with sex, admitted unit, and type of infection.
Conclusions: Strict policies for antibiotic use, cautious decisions regarding the implementation of invasive procedures, and careful management of patients with catheters, especially intravascular catheters, are necessary to handle CRKP infection.
Keywords: Bloodstream infection; Carbapenem resistance; Chronic liver diseases; Klebsiella pneumoniae; Risk factor.
Copyright © 2022 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors declare no competing interest.
Comment in
-
Clinical management of infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: A nationwide survey of tertiary hospitals in mainland China.J Infect. 2022 Jun;84(6):e108-e110. doi: 10.1016/j.jinf.2022.03.023. Epub 2022 Mar 31. J Infect. 2022. PMID: 35367511 No abstract available.
-
A novel clinical therapy to combat infections caused by Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae.J Infect. 2022 Aug;85(2):174-211. doi: 10.1016/j.jinf.2022.05.004. Epub 2022 May 10. J Infect. 2022. PMID: 35637031 No abstract available.
-
Risk factors and clinical impact associated with infections caused by different types of carbapenem-resistant Klebsiella pneumoniae in China: A clinical study from 2014 to 2017.J Infect. 2022 Oct;85(4):436-480. doi: 10.1016/j.jinf.2022.05.045. Epub 2022 Jun 18. J Infect. 2022. PMID: 35728644 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
